Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GRANULES | NSE
-23.50
-2.98%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
08/06/2026
766.35
775.00
797.50
761.00
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs) pharmaceutical formulation intermediates and finished dosages (FDs) in India North America Europe Latin America Africa the Middle East and internationally. The company's APIs in various therapeutic categories include anti-retrovirals anti-hypertensives anti-histamines anti-infectives analgesics anti-coagulants anti-fibriotics and platelet inhibitors. It also offers various FDs such as tablets caplets and press-fit capsules in bulk blister packs and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad India.
View LessLow Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Smallcap (300M - 2B USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
27.7%1 month
30.1%3 months
30.6%6 months
31.6%29.41
15.41
4.47
0.41
0.24
16.11
3.27
-
9.72B
185.74B
1.94B
0.25
17.49
180.30
19.70
13.38
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
51.75
Range1M
83.15
Range3M
251.65
Rel. volume
0.42
Price X volume
422.86M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Eris Lifesciences Limited | ERIS | Drug Manufacturers-Specialty & Generic | 1365.1 | 186.06B | -0.01% | 48.08 | 107.55% |
| Syngene International Limited | SYNGENE | Biotechnology | 449.5 | 180.33B | 3.51% | 71.45 | 13.66% |
| Caplin Point Laboratories | CAPLIPOINT | Drug Manufacturers-Specialty & Generic | 2111 | 160.46B | 3.83% | 30.77 | 0.09% |
| NATCO Pharma Limited | NATCOPHARM | Drug Manufacturers-Specialty & Generic | 868.3 | 155.52B | -2.81% | 15.31 | 6.34% |
| Jubilant Pharmova Limited | JUBLPHARMA | Drug Manufacturers-Specialty & Generic | 957.35 | 149.45B | -1.67% | 33.46 | 67.43% |
| Alembic Pharmaceuticals Limited | APLLTD | Drug Manufacturers-Specialty & Generic | 745.5 | 149.39B | 0.96% | 36.23 | 10.65% |
| Concord Biotech Limited | CONCORDBIO | Biotechnology | 1196.7 | 126.37B | -1.09% | 67.34 | 0.64% |
| PGHL | PGHL | Drug Manufacturers-Specialty & Generic | 6199.5 | 102.24B | -0.01% | 42.84 | 1.78% |
| JUBILANT INGREVIA LTD | JUBLINGREA | Biotechnology | 618 | 96.45B | -1.32% | 67.54 | 27.04% |
| Strides Pharma Science Limited | STAR | Drug Manufacturers-Specialty & Generic | 1005.7 | 93.30B | -3.72% | n/a | 118.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 397.35 | 97.19B | -1.99% | 84.26 | 27.74% |
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 40.65 | 35.66B | 4.96% | 48.67 | 10.74% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 103.93 | 15.31B | -2.36% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 260.2 | 15.25B | -1.87% | 30.54 | 80.30% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 293.15 | 9.47B | -4.40% | 36.36 | 52.08% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 236.95 | 8.45B | -4.45% | 120.49 | 191.28% |
| Madhav Copper Limited | MCL | Copper | 58.99 | 1.63B | -1.02% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 86.1 | 1.25B | -0.94% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 70 | 780.42M | -0.65% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 24.98 | 433.65M | 1.54% | 58.62 | 43.14% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 16.11 | 24.85 | Cheaper |
| Ent. to Revenue | 3.27 | 11.40 | Cheaper |
| PE Ratio | 29.41 | 51.36 | Cheaper |
| Price to Book | 4.47 | 6.83 | Cheaper |
| Dividend Yield | 0.25 | 0.52 | Poor |
| Std. Deviation (3M) | 30.62 | 42.17 | Lower Risk |
| Debt to Equity | 0.41 | 0.35 | Par |
| Debt to Assets | 0.24 | 0.17 | Expensive |
| Market Cap | 185.74B | 290.82B | Emerging |